Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Active not recruiting 4 Suspended 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11 Thoracic 10 Other solid neoplasm 9 Genitourinary 9 Gastrointestinal 8 Other 4 Other hematologic neoplasm 2 Gynecologic 2 Dermatologic 2 CNS 2 Tumor-Agnostic 1 Sarcoma 1 Other neoplasm 1 Lymphoid 1 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 174 Rituximab 146 venetoclax 82 Specimen Handling 81 fludarabine 80 Vincristine 69 obinutuzumab 68 Prednisone 66 Doxorubicin 66 Biopsy 63 Magnetic Resonance Spectroscopy 62 Lenalidomide 54 zanubrutinib 52 Dexamethasone 48 Cytarabine 44 Methotrexate 43 blinatumomab 41 Immunotherapy, Adoptive 40 acalabrutinib 37 Bendamustine Hydrochloride 37 fludarabine phosphate 32 Etoposide 32 ibrutinib 30 polatuzumab vedotin 27 glofitamab 27 pirtobrutinib 25 orelabrutinib 25 Gemcitabine 24 Injections 21 Mercaptopurine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Educational Status × Lymphoid × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡